
Transactions: Healthcare
Filter


Rights issue in Medivir (SE) — SEK 225 million

Secondary placing of 1.7 million shares in Clavis Pharma ASA (NO) — NOK 84 million

Secondary placing of shares in William Demant Invest (DK) — DKK 1.3 billion

Convertible rights issue in Elekta (SE) — SEK 467 million

Secondary offering and initial public offering of OXiGENE Inc. (US) — USD 29 million

Private placement of equity in M&E Biotech A/S (DK) — DKK 32 million

Rights issue in Karo Bio (SE) — SEK 125 million

Divestment of Swedish Orphan International AB (SE) to Investor Growth Capital (SE) and Skandia Investment (SE) — Amount not disclosed.

Secondary placing of 3 million shares in Meda (SE) — SEK 720 million

Rights offering in Medivir (SE) — SEK 325 million
